ENSIGN GROUP (ENSG) Company Report

Ensign Group reported Q3 2025 GAAP diluted earnings per share of $1.42 and adjusted diluted earnings per share of $1.64, representing increases of 6% and 18% respectively. Consolidated GAAP and adjusted revenues were $1.3 billion, an increase of 19.8%.
The company raised its 2025 annual earnings guidance to between $6.48 and $6.54 per diluted share and its annual revenue guidance to between $5.05 billion and $5.07 billion. The new midpoint for earnings guidance represents an 18.4% increase over 2024 results.
During Q3 2025, Ensign Group added 22 new operations, including 10 real estate assets, bringing the total acquisitions for 2025 to 45. These additions included 1,857 new skilled nursing beds and 109 senior living units across six states.
Standard Bearer Healthcare REIT generated $32.6 million in rental revenue for the quarter, with $19.3 million in FFO, and maintained an EBITDA to rent coverage ratio of 2.5 times.

Nov 4, 2025, 6:00 PM

Transcript

Ensign Group Reports Strong Q3 2025 Results and Raises Full-Year Guidance

ENSG

Earnings

Guidance Update

M&A

Ensign Group reported strong Q3 2025 financial results, with adjusted diluted earnings per share increasing 18% to $1.64 and consolidated revenues rising 19.8% to $1.3 billion.
The company raised its full-year 2025 guidance, with annual earnings now projected between $6.48-$6.54 per diluted share and annual revenue between $5.05 billion-$5.07 billion.
Operational performance saw Same-Store and transitioning occupancy reach all-time highs of 83% and 84.4%, respectively, driven by increases in skilled days and Medicare/managed care revenues.
During Q3 2025, Ensign Group accelerated growth by adding 22 new operations, bringing the total acquisitions for 2025 to 45, and its Standard Bearer real estate portfolio grew to 149 owned properties.

Nov 4, 2025, 6:00 PM

Transcript

Ensign Group Reports Strong Q3 2025 Results and Raises Full-Year Guidance

ENSG

Earnings

Guidance Update

M&A

The Ensign Group reported strong financial results for Q3 2025, with GAAP diluted earnings per share of $1.42, an increase of 6%, and adjusted diluted earnings per share of $1.64, up 18%. Consolidated GAAP and adjusted revenues both reached $1.3 billion, marking a 19.8% increase.
The company raised its annual 2025 earnings guidance to between $6.48-$6.54 per diluted share and its annual revenue guidance to between $5.05 billion and $5.07 billion.
Operational highlights include Same-Store and transitioning occupancy reaching all-time highs of 83% and 84.4%, respectively. Skilled days increased by 5.1% for Same-Store and 10.9% for transitioning operations over the prior year quarter.
During Q3 2025, Ensign accelerated its growth by adding 22 new operations, including 10 real estate assets, totaling 1,857 new skilled nursing beds and 109 senior living units across six states, bringing the total acquisitions for 2025 to 45.
The company maintains a strong financial position with $443.7 million in cash and cash equivalents and $593 million of available capacity under its line of credit as of September 30, 2025, providing over $1 billion in dry powder for future investments.

Nov 4, 2025, 6:00 PM

Transcript

Ensign Group Reports Strong Q3 2025 Results and Raises Full-Year Guidance

ENSG

Earnings

Guidance Update

M&A

The Ensign Group reported GAAP diluted earnings per share of $1.42 and adjusted diluted earnings per share of $1.64 for the third quarter ended September 30, 2025.
Consolidated GAAP and adjusted revenue for Q3 2025 was $1.30 billion, an increase of 19.8% over the prior year quarter.
The company raised its annual 2025 earnings guidance to between $6.48 to $6.54 per diluted share and annual revenue guidance to $5.05 billion to $5.07 billion.
Same Facilities occupancy for the quarter was 83.0%, and Transitioning Facilities occupancy was 84.4%, representing increases of 2.1% and 3.6% respectively over the prior year quarter.
As of September 30, 2025, the company maintained strong liquidity with approximately $443.7 million of cash on hand and $592.6 million of available capacity under its line-of-credit.

Nov 3, 2025, 9:18 PM

8-K

Ensign Group Reports Strong Q3 2025 Results and Raises Annual Guidance

ENSG

Earnings

Guidance Update

M&A

The Ensign Group reported Q3 2025 GAAP diluted earnings per share of $1.42 and adjusted earnings per share of $1.64, with consolidated GAAP and adjusted revenue reaching $1.30 billion, marking a 19.8% increase over the prior year quarter.
The company raised its annual 2025 earnings guidance to between $6.48 to $6.54 per diluted share and its annual revenue guidance to $5.05 billion to $5.07 billion.
Occupancy rates for Same Facilities and Transitioning Facilities increased to 83.0% and 84.4% respectively in Q3 2025, while the company continued its growth strategy by adding 22 new operations during the quarter and since, totaling 45 acquisitions in 2025.
Ensign maintains strong liquidity with approximately $443.7 million of cash on hand and $592.6 million of available capacity under its line-of-credit, and paid a quarterly cash dividend of $0.0625 per share.

Nov 3, 2025, 9:07 PM

Press Release

Ensign Group Completes Multiple Acquisitions

ENSG

M&A

New Projects/Investments

Ensign Group acquired the operations of The Health Center of Eastview, a 90-bed skilled nursing facility in Birmingham, Alabama, effective November 1, 2025.
In a separate transaction on the same day, Ensign also acquired the real estate and operations of seven skilled nursing facilities in Utah.
These acquisitions expand Ensign's portfolio to 369 healthcare operations across 17 states, with 155 real estate assets owned by its subsidiaries.

Nov 3, 2025, 11:00 AM

Press Release

Ensign Group Reports Strong Q2 2025 Results and Raises Full-Year Guidance

ENSG

Earnings

Guidance Update

M&A

Ensign Group Inc. (ENSG) reported strong Q2 2025 financial results, with GAAP diluted EPS of $1.44 (up 18%) and adjusted diluted EPS of $1.59 (up 20.5%), on consolidated revenue of $1.2 billion (up 18.5%).
The company raised its annual 2025 earnings guidance to between $6.34 and $6.46 per diluted share and its annual revenue guidance to between $4.99 billion and $5.02 billion, reflecting strong performance and anticipated acquisitions.
Operational highlights for Q2 2025 include record same-store and transitioning occupancy increases of 24.6% to 82.184% respectively, and skilled census increases of 7.4% and 13.5% respectively over the prior year quarter.
ENSG maintained a strong financial position as of June 30, 2025, with $364 million in cash and cash equivalents, $228 million in cash flow from operations, a lease adjusted net debt to EBITDA ratio of 1.97x, and over $1 billion in dry powder for future investments.
The company continued its growth strategy by adding eight new operations during the quarter and since, bringing the total acquired in 2024 to 52, and its real estate arm, Standard Bear, added five new assets, now owning 140 properties.

Jul 25, 2025, 10:10 PM

Ensign Group Chairman Christensen to Retire, CEO Port to Become Board Chair

ENSG

CEO Change

Board Change

Management Change

Executive Chairman Christopher Christensen will retire effective September 1, 2025, with CEO Barry R. Port assuming the additional role of Board Chair while retaining his CEO duties.
Marivic Uychiat, a 22-year healthcare veteran and EVP of Clinical Services since 2016, has been appointed to Ensign’s Board of Directors.
The transition is part of an orderly succession plan aimed at ensuring strategic continuity and stability; analysts view Port’s dual role positively but note some transitional risks.
Ensign operates 347 healthcare facilities across 17 states under a decentralized model credited with strong clinical and financial performance.

Jun 20, 2025, 9:08 PM

Morningstar

Ensign Group Holds 2025 Annual Meeting Voting Results

ENSG

Proxy Vote Outcomes

Auditor Change

Executive Compensation

The 2025 Annual Meeting of Stockholders was held on May 15, 2025 with a record date of March 20, 2025; 57,626,065 shares were eligible to vote and 53,021,533 shares were represented in person or by proxy.
Four board director nominees were elected, including Mark V. Parkinson for a two-year term and Dr. Ann S. Blouin, Dr. John O. Agwunobi, and Mr. Barry R. Port for three-year terms, with detailed voting results provided.
The meeting also resulted in the ratification of Deloitte & Touche LLP as the independent auditor, advisory approval of executive compensation, and approval of the amendment to the 2022 Omnibus Incentive Plan.

May 20, 2025, 12:00 AM

8-K

Earnings Transcripts

Quarterly earnings call transcripts for ENSIGN GROUP.

Ask Fintool AI Agent

Get instant answers from SEC filings, earnings calls & more

What did Barry Port say about margins?What are ENSIGN GROUP's strategic priorities?How is ENSIGN GROUP positioned vs competitors?How did ENSIGN GROUP do last quarter?

Let Fintool AI Agent track ENSIGN GROUP's earnings for you

Get instant analysis when filings drop